Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma

Biomarkers for FH-deficient renal cell carcinoma identified.

patients FH-deficient tumors tumors renal cell carcinoma
6 Disease terms
2 Chemical terms
1 Organisms

Study details

Title
Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
Summary
Biomarkers for FH-deficient renal cell carcinoma identified.
Observation
Plasma metabolomics in FH-deficient RCC patients.
Findings
Succinyl-adenosine and succinic-cysteine are biomarkers with >90% predictive value.
Disease terms
FH-deficient tumors, tumors, renal cell carcinoma, tumor, RCC, fumarate hydratase-deficient renal cell carcinoma
Gene terms
FH, fumarate hydratase
Chemical terms
succinyl-adenosine, succinate
Organisms
patients

Raw data (JSON)

Also available at /api/study/https://identifiers.org/metabolights:MTBLS3628.